We attempted to determine whether changes in protein kinase C (PKC) ac
tivity in Alzheimer's disease (AD) brains are also present in cultured
skin fibroblasts from living patients. Biopsies collected from should
er skin were transferred to culture plates with an appropriate growth
medium, and histone-directed PKC activity as well as phorbol ester bin
ding were individually determined in soluble and particulate fractions
prepared from AD and non-AD fibroblast cell lines. Binding experiment
s indicated that PKC was unevenly distributed between cytosol (78%) an
d particulate (22%). The B(max) values for phorbol ester binding in so
luble and particulate fractions were similar in AD and non-AD patients
. K(d) values in the cytosol were 94% higher in AD patients, indicatin
g lower affinity of the enzyme for the ligand. Accordingly, the solubl
e PKC activity was 30% lower in AD patients. The data suggest that the
changes in PKC phosphorylating activity represent a diffuse cellular
defect in AD and are not confined to the brain. The alterations of the
enzyme may participate in the disregulation in processing of beta-amy
loid precursor protein in AD.